Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Biochip Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are Abbott, Agilent Technologies, Illumina, PerkinElmer & Thermo Fisher Scientific

Research and Markets
Posted on: 05 Sep 17
Global Biochip Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are Abbott, Agilent Technologies, Illumina, PerkinElmer & Thermo Fisher Scientific

PR Newswire

DUBLIN, September 5, 2017

DUBLIN, September 5, 2017 /PRNewswire/ --

The "Global Biochip Market 2017-2021" report has been added to Research and Markets' offering.

The global biochip market is forecast to grow at a CAGR of 17.53% during the period 2017-2021.

The report, Global Biochip Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is growth in bioinformatics software industry. Bioinformatics software is a tool that is used in data collection, mining, database construction, and analysis of data. This tool is used in to create analysis results out of the massive amount of data that had been already collected. Along with this, bioinformatics software is also used in the field of genomics and proteomics. It helps in the identification and analysis of abnormalities in the genome of an organism.

According to the report, one driver in the market is increase in market presence with collaboration strategy. The competition in this market is intense as the number of players is high. The players are competing among themselves based on technology and price. Apart from these two factors, another factor that differentiates these competitors from each other is their presence in the market. Players increase their market presence by collaborating with those companies that own bio-content. Research says that companies generate around 60% better results when they work in collaborations. This increases their profit margins. They collaborate with each other for R&D, financial resources, and intellectual properties.

Key vendors

  • Abbott
  • Agilent Technologies
  • Illumina
  • PerkinElmer
  • Thermo Fisher Scientific

Other prominent vendors

  • BioChain
  • Bio-Rad Laboratories
  • Cepheid
  • EMD Millipore
  • Fluidigm
  • SuperBioChips Laboratories
  • US Biomax

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market segmentation by fabrication technology

PART 06: Geographical segmentation

PART 07: Decision framework

PART 08: Drivers and challenges

PART 09: Market trends

PART 10: Vendor landscape

PART 11: Key vendor analysis

PART 12: Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

PR Newswire

Last updated on: 05/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.